Drug Profile
Terbinafine transungual solution - Polichem
Alternative Names: ALM-12834; P-3058Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Polichem
- Class Amines; Antifungals; Naphthalenes; Skin disorder therapies; Small molecules
- Mechanism of Action Cell membrane modulators; Squalene monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Onychomycosis
Most Recent Events
- 22 Mar 2023 Medexus Pharmaceuticals enters in agreement with Polichem to commercialize terbinafine in Canada when approved
- 25 Jul 2022 No development reported - Preregistration for Onychomycosis in European Union (Topical) (Polichem pipeline, July 2022)
- 17 Sep 2018 Polichem completes a phase III trial in Onychomycosis (In Childrens, In adolescents, In the elderly, In adults) in Belgium, Bulgaria, Czech Republic, Germany, Greece, Iceland,Latvia, Lithuania, Poland, Slovakia, Russia & Sweden (Topical)(NCT02549001)